期刊文献+

慢性肾小球肾炎非尿毒症期患者血、尿NO与血压的关系 被引量:1

The change of serum and urinary NO and the relation between NO and blood pressure in patients with chronic glomerulonephritis at pre-uremic phase
暂未订购
导出
摘要 目的 :探讨慢性肾小球肾炎非尿毒症期患者体内一氧化氮 (NO)的变化 ,及其与血压的关系。方法 :应用化学比色法 ,测定 92例慢性肾炎非尿毒症期患者及 31例正常人的血清、尿NO-3 /NO-2 变化。结果 :慢性肾炎非尿毒症期患者血清及尿NO-3 /NO-2 水平较对照组显著降低 (P <0 .0 1) ;慢性肾炎非尿毒症期患者高血压组血清及尿NO-3 /NO-2 水平显著低于血压正常组及正常对照组 ,血压正常组尿NO-3 /NO-2 水平显著低于正常对照组 (P <0 .0 5 ) ;患者组血清及尿NO-3 /NO-2 水平均与平均动脉压呈显著负相关。结论 :慢性肾炎非尿毒症期患者高血压的发生可能与体内NO水平不足密切相关。 Objective:To observe the change of serum and urinary nitric oxide (NO) and the relation between NO and blood pressure in chronic glomerulonephritis (CGN) patients at pre-uremic phase.Methods:The levels of serum and urinary NO - 3/NO - 2 were measured in 92 cases of CGN at pre-uremic phase and 31 normal subjects by chemical colorimetry.Results:The levels of serum and urinary NO - 3/NO - 2 in CGN patients at pre-uremic phase were significantly lower than those in the control group.The levels of serum and urinary NO - 3/NO - 2 of the hypertension group were significantly lower than those of the normal blood pressure group and the control group;furthermore,the levels of urinary NO - 3/NO - 2 of the normal blood pressure group were significantly lower than those of the control group.There was significantly inverse correlation between the levels of serum NO - 3/NO - 2 and mean arterial pressure (MAP),and also there was significantly inverse correlation between the levels of urinary NO - 3/NO - 2 and MAP.Conclusion:In CGN patients at pre-uremic phase,hypertension may be related to the insufficiency of NO.
出处 《重庆医科大学学报》 CAS CSCD 2003年第4期493-495,共3页 Journal of Chongqing Medical University
关键词 慢性肾小球肾炎 一氧化氮 血压 Chronic glomerulonephritis Nitric oxide Blood pressure
  • 相关文献

参考文献7

  • 1Gatcia-Cardena G, Fan R, Stern DF, et al. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin - 1 [J]. J Biol Chem, 1996; 271(44) :27237 - 27240.
  • 2Vallance P, Leone A, Calver A, et al. Accumulation of endogenous inhibitor of nitric oxide synthesis in chronic renal failure[J ]. Lancet, 1992; 339(8793) : 572 - 575.
  • 3Kielstein JT, Boger RH, Bode- Boger SM,et al. Asymmetric dimethylarginine plasma concentrations differ in patients with end- stage renal disease: relationship to treatment method and atherosclerotic disease[J] .J Am Soc Nephrol, 1999; 10(3) :594 - 600.
  • 4Noris M, Remuzzi G. Physiology and pathophysiology of nitric oxide in chronic renal disease[J]. Proc Assoc Am Physicians, 1999; 111(6) :602 - 610.
  • 5Richard V, Hogie M,Clozel M,et al. In vivo evidence of an endothelin- induced vasopressor tone after inhibition of nitric oxide synthesis in rats[ J ]. Circulation, 1995; 91 (3) : 771 - 775.
  • 6Noll G, Wenzel RR, Lüscher TF. Endothelin and endothelin antagonists: potential role in cardiovascular and renal disease[ J ]. Mol Cell Biochem, 1996; 157( 1 - 2) :259 - 267.
  • 7Linder L, Kiowski W, Bühler FR, et al. Indirect evidence for release of endothelium- derived relaxing factor in human forearm circulation in vivo[ J ]. Circulation, 1990; 81 (6) : 1762 -1767.

同被引文献6

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部